{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:37:13Z","timestamp":1787726233627,"version":"build-2784847793"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Post-transplant infections are common complications, and the reasons are pre-transplant conditioning, time required for post-transplant immune reconstitution, and use of immunosuppressive agents. We aimed to analyze the risk factors for Epstein\u2013Barr virus (EBV) reactivation and its progression to post-transplant lymphoproliferative disorder (PTLD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children and to determine the EBV PCR diagnostic threshold for PTLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analyzed clinical data of 309 patients who underwent allo-HSCT without engraftment failure at the Children's Hospital of Chongqing Medical University from January 1, 2016, to December 21, 2021. The occurrences of EBV reactivation and PTLD were also recorded. The risk factors for EBV reactivation and progression to PTLD were analyzed, and the diagnostic threshold for PTLD was determined using whole-blood EBV PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 309 pediatric patients, 256 experienced EBV reactivation within one year and 12 progressed to PTLD. Univariate and multivariate analyses indicated that ATG was the independent risk factor for EBV reactivation. Grade III-IV acute graft-vs.-host disease (aGVHD) was the risk factor for PTLD after EBV reactivation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Post-transplant EBV reactivation is a common complication after allo-HSCT, but rarely progresses to PTLD. Identification of the risk factors for PTLD and regular monitoring of the EBV-DNA load play important roles in prevention and cure of PTLD after HSCT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1627990","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T05:25:46Z","timestamp":1752729946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of risk factors for Epstein\u2013Barr virus reactivation and progression to post-transplant lymphoproliferative disorder in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation"],"prefix":"10.3389","volume":"13","author":[{"given":"Lanzhou","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","article-title":"The extent of genetic diversity of Epstein\u2013Barr virus and its geographic and disease patterns: a need for reappraisal","volume":"143","author":"Chang","year":"2009","journal-title":"Virus Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein\u2013Barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: sixth European conference on infections in leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.bbmt.2019.02.016","article-title":"Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation","volume":"25","author":"Fujimoto","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00277-021-04428-9","article-title":"Impact of donor and recipient Epstein\u2013Barr virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"100","author":"Ko\u0142odziejczak","year":"2021","journal-title":"Ann Hematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41409-020-01121-9","article-title":"Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children","volume":"56","author":"Kang","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcv.2017.10.016","article-title":"Epstein\u2013Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: is it of any clinical usefulness?","volume":"97","author":"Solano","year":"2017","journal-title":"J Clin Virol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00432-018-2674-9","article-title":"The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients","volume":"144","author":"Wareham","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00277-019-03603-3","article-title":"Incidence, risk factors, and clinical significance of Epstein\u2013Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation","volume":"98","author":"Wang","year":"2019","journal-title":"Ann Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/s41409-020-0831-7","article-title":"Epstein\u2013Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes","volume":"55","author":"Ru","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jcyt.2018.02.367","article-title":"Epstein-Barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder","volume":"20","author":"Kalra","year":"2018","journal-title":"Cytotherapy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3324\/haematol.2013.087338","article-title":"Risk factors for Epstein\u2013Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation","volume":"99","author":"Uhlin","year":"2014","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41409-019-0699-6","article-title":"Pre-emptive rituximab treatment for Epstein\u2013Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes","volume":"55","author":"Stocker","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1080\/10428194.2017.1365860","article-title":"Long-term outcome of Epstein\u2013Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT","volume":"59","author":"Kinch","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00277-019-03742-7","article-title":"Risk factors and clinical outcomes of Epstein\u2013Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies","volume":"98","author":"Gao","year":"2019","journal-title":"Ann Hematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1080\/10428194.2020.1797010","article-title":"High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis","volume":"61","author":"Salas","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e13719","DOI":"10.1111\/tid.13719","article-title":"Dynamics of Epstein\u2013Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant","volume":"23","author":"Lindsay","year":"2021","journal-title":"Transplant Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"903063","DOI":"10.3389\/fimmu.2022.903063","article-title":"Epstein\u2013Barr virus reactivation after paediatric haematopoietic stem cell transplantation: risk factors and sensitivity analysis of mathematical model","volume":"13","author":"Kania","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bjh.15037","article-title":"Inverse correlation of V\u03b42(+) T-cell recovery with EBV reactivation after haematopoietic stem cell transplantation","volume":"180","author":"Liu","year":"2018","journal-title":"Br J Haematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1128\/JCM.02571-13","article-title":"Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?","volume":"52","author":"Gim\u00e9nez","year":"2014","journal-title":"J Clin Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/diagnostics13030476","article-title":"Diagnostic value of whole-blood and plasma samples in Epstein\u2013Barr virus infections","volume":"13","author":"Rzepka","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"155902","DOI":"10.1016\/j.cyto.2022.155902","article-title":"Study on diagnostic value of results of EB virus nucleic acid quantification in whole blood lymphocyte and serum in children with EB virus infection","volume":"155","author":"Gao","year":"2022","journal-title":"Cytokine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3324\/haematol.2020.271445","article-title":"Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation","volume":"107","author":"Massoud","year":"2022","journal-title":"Haematologica"},{"key":"B24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","article-title":"Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial","volume":"17","author":"Walker","year":"2016","journal-title":"Lancet Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3389\/fimmu.2019.01997","article-title":"Improved overall survival, relapse-free-survival, and less graft-vs.-host-disease in patients with high immune reconstitution of TCR gamma Delta cells 2 months after allogeneic stem cell transplantation","volume":"10","author":"Minculescu","year":"2019","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1200\/JCO.20.00150","article-title":"Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study","volume":"38","author":"Chang","year":"2020","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.bbmt.2015.07.035","article-title":"Epstein\u2013Barr virus-related post-transplantation lymphoproliferative disorder after unmanipulated human leukocyte antigen haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes","volume":"21","author":"Xu","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/bmt.2016.238","article-title":"Association of Epstein\u2013Barr virus reactivation with the recovery of CD4\/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation","volume":"52","author":"Bian","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2015-08-665000","article-title":"Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event","volume":"126","author":"Burns","year":"2015","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e13150","DOI":"10.1111\/ctr.13150","article-title":"Risk factors for post-transplant lymphoproliferative disorder after thymoglobulin-conditioned hematopoietic cell transplantation","volume":"32","author":"Kalra","year":"2018","journal-title":"Clin Transplant"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1627990\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T05:25:47Z","timestamp":1752729947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1627990\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":31,"alternative-id":["10.3389\/fped.2025.1627990"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1627990","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"article-number":"1627990"}}